학술논문
Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes
Document Type
Article
Author
Source
In: Diabetes . (Diabetes, December 2021, 70(12):2810-2822)
Subject
Language
English
ISSN
1939327X
00121797
00121797